Cytosorbents Corp Files 8-K on Financials
Ticker: CTSO · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
CYTOSORBENTS CORP FILED AN 8-K ON 3/21/25 DETAILING FINANCIALS AND OPERATIONS.
AI Summary
Cytosorbents Corporation filed an 8-K on March 21, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company was formerly known as MedaSorb Technologies CORP and GILDER ENTERPRISES INC.
Why It Matters
This 8-K filing provides investors with crucial updates on Cytosorbents Corporation's financial performance and operational status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not appear to contain any immediate negative news.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- MedaSorb Technologies CORP (company) — Former Company Name
- GILDER ENTERPRISES INC (company) — Former Company Name
- March 21, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Cytosorbents Corporation's results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on March 21, 2025.
What were Cytosorbents Corporation's previous names?
Cytosorbents Corporation was formerly known as MedaSorb Technologies CORP and GILDER ENTERPRISES INC.
In which state is Cytosorbents Corporation incorporated?
Cytosorbents Corporation is incorporated in Delaware.
What is the principal executive office address for Cytosorbents Corporation?
The principal executive office address for Cytosorbents Corporation is 305 College Road East, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Cytosorbents Corp (CTSO).